Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research.

Béatrice GouyonSéverine Martin-MonsSilvia IacobelliHasinirina RazafimahefaElsa Kermorvant-DucheminRoselyne BratLaurence CaeymaexYvan CouringaCeneric AlexandreCatherine LafonDuksha RamfulFrancesco BonsanteGuillaume BinsonFlorence FlameinAmélie Moussy-DurandyMassimo Di MaioGaël MazeirasOlivier GirardCécile DesbruyeresJulien MourdieGuillaume EscourrouOlivier FlechellesSoumeth AbasseJean-Marc RosenthalAnne-Sophie PagesMarine DorsiLéila KaraouiAbdellah ElGellabFlorence Le Bail DantecMohamed-Amine YanguiKarine NorbertYaovi KugbeSimon LorrainAnaelle PignoletElodie Marie GarnierAlexandre LapillonneDelphine MitanchezEvelyne Jacqz-AigrainJean-Bernard Gouyon

Published in: PloS one (2019)

Neonates remain therapeutic orphans. The consequences of polypharmacy in L3NW should be quickly assessed, especially in the most immature infants.

Keyphrases

current status
low birth weight
psychometric properties
adverse drug
emergency department